Flourish Research Leaders

The Flourish Research leadership team oversees network operations and integrations.

Reinhold Schulz

Chief Executive Officer

Reinhold Schulz

Chief Executive Officer

Reinhold Schulz is a seasoned pharmaceutical services executive, with a background that spans decades of industry experience. Most recently, he led the Global Site Network at Accelerated Enrollment Solutions, a business of PPD, which is a leading global contract research organization. In this role, he had oversight of more than 160 clinical research sites and 1,300 employees in 15 countries. Prior to this, he served as the Head of Early Development clinical research sites at PPD. Before joining PPD, he spent 17 years at PAREXEL in various roles supporting the company’s clinical research site strategy.

Reinhold holds a Bachelor of Science in Chemistry, Biochemistry, and Physiology and a Bachelor’s in Medical Science in Pharmacology from University of Free State, Bloemfontein South Africa.  Reinhold also holds a Master of Business Administration from University of Phoenix.

Chris Duignan

Chief Financial Officer

Chris Duignan

Chief Financial Officer

Chris Duignan is a senior financial executive with over twenty-five years of experience, the last fourteen years at life science companies. Chris was most recently the VP of Finance at ERG Clinical, an independent clinical research site company comprised of 21 wholly owned clinical sites. Chris spent over two years at ERG assisting with their company-wide accounting system implementation as well as their transition over to one clinical trial management system.

Prior to ERG Chris spent six years as the VP of Finance at the New York Genome Center, a privately held DNA sequencing center, one of the four largest in the world. Chris built the financial infrastructure of NYGC, implementing the accounting system (SAP Business 1), the DNA tracking system through the LIMS, and the federal grant reporting system. Before that Chris was the VP of Finance at Kadmon, a then privately held, start-up pharmaceutical company, where Chris implemented Oracle as the organization’s first ERP system. Prior to Kadmon Chris was the VP of Finance at NeoStem, a publicly traded stem cell technology company where Chris led the integration of NeoStem’s acquisition of a Chinese pharmaceutical company.

Before NeoStem Chris was the Chief Financial Officer at Enliven, a publicly traded online advertising and technology company. Chris spent six years at Enliven, raising $15M in two private placements, acquired two companies, and sold Enliven.

Chris started his career at PricewaterhouseCoopers spending four years in the audit practice of the technology group. Chris graduated with an accounting degree from Fairfield University in Connecticut. Chris also spent six years in the United States Marine Corps Reserve serving in an infantry unit during his time at Fairfield and first two years at PwC.


Seth J. Baum - Chief Scientific Officer - Flourish Research

Seth J. Baum, MD, FACC, FAHA, FNLA, FASPC

Chief Scientific Officer

Seth J. Baum - Chief Scientific Officer - Flourish Research

Seth J. Baum, MD, FACC, FAHA, FNLA, FASPC

Chief Scientific Officer

Dr. Seth J. Baum, Chief Scientific Officer of Flourish Research, is a graduate of Columbia College and Columbia College of Physicians and Surgeons, completed training in Internal Medicine, Cardiology, Interventional Cardiology, and Electrophysiology.  

Dr. Baum is a fellow of the American College of Cardiology, the American Heart Association, the American College of Preventive Medicine, the National Lipid Association, and the American Society for Preventive Cardiology. He is a past President of the American Society for Preventive Cardiology (ASPC). He currently sits on The Family Heart Foundation LP(a) Advisory Board. He has published over 100 peer-reviewed papers and abstracts – many in top-tier journals such as the New England Journal of Medicine, JAMA, Lancet, JACC, and Nature – as well as two books.

In 2013, he was awarded Cleveland Heart Lab’s “Heart Award” for lifelong dedication to Preventive Medicine. In 2019, Mended Hearts honored him with its biennial Dwight Emary Harken Award. Dr. Baum is the Founder and Chief Medical Officer of Flourish Boca Raton, FL which began as Excel Medical Clinical Trials. As Principal Investigator in novel drug development he has contributed significantly to the advancement of therapeutics in disease states ranging from ultra-rare to common.

Dr. Baum is clinical affiliate professor of Cardiology at FAU Medical School, runs the only lipoprotein apheresis center in southeast Florida, and consults in Clinical Lipidology and Preventive Cardiology.

Learn more about Flourish Boca Raton, FL

Ana Marquez - Chief Diversity Officer

Ana Marquez

Chief Diversity Officer

Ana Marquez - Chief Diversity Officer

Ana Marquez

Chief Diversity Officer

Ana T. Marquez, MSF, CRCP, is the Chief Diversity Officer for Flourish and CEO/Co-Founder of Flourish Orlando, Miami and Leesburg, which began as Clinical Site Partners. She has experience coordinating protocols, building teams, expanding therapeutic indications, auditing trials, creating site processes, and implementing administrative/financial policies to increase site efficiency. Ana has also negotiated hundreds of clinical trial agreements and budgets. Additionally, she assisted numerous research facilities with site expansion, A/R process implementation, and new investigator training. At the sponsor level, Ana has served as a consultant on Phase I-IV projects, assisting with the feasibility process, protocol design, trial budgets, and site selection.

Ana is highly proactive in the research industry, presenting at major industry conferences, serving on various sponsor/CRO advisory groups through the Society for Clinical Research Sites (SCRS) and the Association of Clinical Research Professionals. She has also served as a Committee Chairman for global organizations such as the Drug Information Association and SCRS. Ana holds a Master of Science degree in Finance from Florida International University.

Steve Satek - Chief Commercial Officer

Steve Satek

Chief Commercial Officer

Steve Satek - Chief Commercial Officer

Steve Satek

Chief Commercial Officer

Steve Satek is the Chief Commercial Officer for Flourish and has more than 30 years of experience in the clinical research industry. He began his career as a bench researcher at the Northwestern University Robert H. Lurie Cancer Center. Since that time has held senior management positions at the Chicago Center for Clinical Research, Radiant Research, Cognitive Drug Research and Forenap Pharma, where he specialized in the design, implementation, and management of central nervous system and clinical pharmacology research programs.

He was previously CEO of Flourish Chicago area sites, formerly known as Great Lakes Clinical Trials. Steve offers a diverse and thorough knowledge of clinical trial operations, which has been presented at over 300 meeting and events.  In addition, he has personally project managed and/or coordinated over 150 clinical trials.

Steve currently serves on the Planning Committee and is former Chairman for the Global Site Solutions Summit, one the clinical research industry’s leading conferences.  He is also an active member of Global Alzheimer’s Platform, a patient-centric, non-profit organization dedicated to speeding the delivery of innovative therapies to those afflicted with Alzheimer’s.

Locally in Chicago, Steve has served on the Board of Directors for the Swedish American Museum, is currently a Board Member for the Andersonville Chamber of Commerce, sits on the Diversity, Equality, and Inclusion Committee for the Andersonville Chamber of Commerce in addition to the Events Committee for the Edgewater Chamber of Commerce. He is also Chairman of the non-profit, Memory Care Coalition of Chicago.  In 2018, Steve was honored to be recognized by Crain’s Chicago Business as one of Chicago’s Notable LGBTQ Executives.

Steve holds two Bachelor of Science degrees in Molecular Biology and in Biochemistry from the University of Wisconsin-Madison and an Executive MBA from the Lake Forest Graduate School of Management.

Discover More About Flourish

Learn more about Flourish Research capabilities and experience.

Learn More